The Band of Angels is a venture capital firm that focuses on seed-stage investments in high-technology and life science companies. Their strategy involves being early investors, often providing the first "organized" capital, to companies with strong teams, proprietary technology, and significant market potential.
43% of their portfolio is in Healthcare. Their most common stage is series-a (57% of deals). Average disclosed round size is $8.2M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$50M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CChampions Round | Series A | $7M | Feb 2023 |
 Raydiant Oximetry, Inc. | Series A | $5M | Nov 2021 |
| UUppidy | Seed | $600K | Mar 2013 |
 Practice Fusion | Series C | $34M | Jun 2012 |
| CCabulous | Series A | $8M | Jun 2012 |
| PPromoJam | Series A | $1.2M | Mar 2012 |
| 1100Plus | Seed | $1.3M | — |
Top Co-Investors
Felicis Ventures2 shared
Founders Fund2 shared
Shasta1 shared
Sand Hill Angels1 shared
Blu Venture Investors1 shared
Golden Seeds1 shared
Avestria1 shared
SteelSky Ventures1 shared
SV Angel1 shared
Glynn Capital1 shared
Morgenthaler Ventures1 shared
Point72 Ventures1 shared
Goodwater Capital1 shared
Pipeline Capital1 shared
Quest1 shared
Gaingels1 shared
Greylock Partners1 shared
Last updated: 21 April 2026